ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

KALA KALA BIO Inc

5,91
-0,09 (-1,50%)
15 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
KALA BIO Inc KALA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,09 -1,50% 5,91 06:00:14
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
6,02 5,90 6,02 5,96 6,00
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
13/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:05EDGAR2Form 8-K - Current report
04/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202422:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/5/202414:00GLOBEKALA BIO to Present at Jefferies Global Healthcare..
14/5/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:06EDGAR2Form 8-K - Current report
14/5/202422:05GLOBEKALA BIO Reports First Quarter 2024 Financial Results and..
29/3/202413:00GLOBEKALA BIO Reports Fourth Quarter and Full Year 2023 Financial..
04/3/202413:30EDGAR2Form 8-K - Current report
26/2/202414:00GLOBEKALA BIO to Present at TD Cowen 44th Annual Healthcare..
14/2/202419:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202414:00GLOBEKALA BIO to Present at Oppenheimer 34th Annual Healthcare..
19/1/202422:01GLOBEKALA BIO Reports Inducement Grants Under Nasdaq Listing Rule..
05/1/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202314:22EDGAR2Form 8-K - Current report
13/11/202314:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202314:05EDGAR2Form 8-K - Current report
13/11/202314:00GLOBEKALA BIO Reports Third Quarter 2023 Financial Results and..
18/10/202322:04EDGAR2Form SC 13D/A - General statement of acquisition of..
20/9/202322:01GLOBEKALA BIO Reports Inducement Grants Under Nasdaq Listing Rule..
05/9/202314:00GLOBEKALA BIO to Present at H.C. Wainwright 25th Annual Global..
04/8/202314:00GLOBEKALA BIO Reports Second Quarter 2023 Financial Results and..
02/8/202322:01EDGAR2Form 8-K - Current report
02/8/202322:01GLOBEKALA BIO to Participate in Upcoming Investor Conferences in..
02/8/202314:00GLOBEKala Pharmaceuticals Announces Name Change to KALA BIO
19/7/202322:01GLOBEKala Pharmaceuticals Reports Inducement Grants Under Nasdaq..
23/6/202322:01GLOBEKala Pharmaceuticals Reports Inducement Grants Under Nasdaq..

Dernières Valeurs Consultées